Literature DB >> 11318546

Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.

R K Linskens1, A A van Bodegraven, M Schoorl, H A Tuynman, P Bartels.   

Abstract

Alterations in markers of coagulation have been found in patients with inflammatory bowel disease. Our aim was to study the predictive value of coagulation and inflammatory parameters in the course of severe ulcerative colitis. Twenty-seven patients were included. The disease course was followed for one year. Sensitivity, specificity, negative predictive value, positive predictive value, and likelihood ratio, as well as the clinical predictive value of laboratory variables were calculated. Inflammatory variables, such as ESR, CRP, and leukocyte and platelet count showed poor diagnostic accuracy. Several coagulation parameters, such as fibrinogen and fibrin(ogen) degradation products, were increased in patients with active ulcerative colitis, whereas coagulation factor XIII was decreased. No significant relationship between clinical course and coagulation parameters was demonstrated, though both inflammatory and coagulation parameters were useful in the assessment of disease activity in patients with active ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318546     DOI: 10.1023/a:1005628005734

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Vascular complications of inflammatory bowel disease.

Authors:  R W Talbot; J Heppell; R R Dozois; R W Beart
Journal:  Mayo Clin Proc       Date:  1986-02       Impact factor: 7.616

2.  Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease.

Authors:  A A Van Bodegraven; H A Tuynman; M Schoorl; A M Kruishoop; P C Bartels
Journal:  Scand J Gastroenterol       Date:  1995-06       Impact factor: 2.423

Review 3.  Assessment of disease severity and activity in inflammatory bowel disease.

Authors:  J Kjeldsen; O B Schaffalitzky de Muckadell
Journal:  Scand J Gastroenterol       Date:  1993-01       Impact factor: 2.423

4.  Predictive value of coagulation markers concerning clinical outcome 90 days after anterior myocardial infarction.

Authors:  C E Dempfle; F Kontny; U Abildgaard
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

Review 5.  Assessment of hypercoagulable states by measurement of activation fragments and peptides.

Authors:  M D Boisclair; H Ireland; D A Lane
Journal:  Blood Rev       Date:  1990-03       Impact factor: 8.250

6.  Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity.

Authors:  R L Edwards; J B Levine; R Green; M Duffy; E Mathews; W Brande; F R Rickles
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

7.  Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases.

Authors:  P Chamouard; L Grunebaum; M L Wiesel; P L Frey; C Wittersheim; R Sapin; R Baumann; J P Cazenave
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-12       Impact factor: 2.566

8.  Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity.

Authors:  F Carbonnel; A Lavergne; M Lémann; A Bitoun; P Valleur; P Hautefeuille; A Galian; R Modigliani; J C Rambaud
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

Review 9.  Drug-induced alterations of hemostasis and fibrinolysis.

Authors:  J Fareed; D Hoppenstedt; R L Bick; P Bacher
Journal:  Hematol Oncol Clin North Am       Date:  1992-12       Impact factor: 3.722

10.  Hemostatic alterations in inflammatory bowel disease: response to therapy.

Authors:  A M Lake; J Q Stauffer; M J Stuart
Journal:  Am J Dig Dis       Date:  1978-10
View more
  10 in total

Review 1.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Plasmatic [corrected] factor XIII reduces severe pleural effusion in children after open-heart surgery.

Authors:  M Schroth; U Meißner; R Cesnjevar; M Weyand; H Singer; W Rascher; J Klinge
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

3.  The role of costimulatory molecules CD80 and CD86 and IFNgamma in the pathogenesis of ulcerative colitis.

Authors:  Marco Scarpa; Roubik Behboo; Imerio Angriman; Barbara Termini; Michela Barollo; Cesare Ruffolo; Lino Polese; Renata D'Incà; Giacomo Carlo Sturniolo; Davide Francesco D'Amico
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

4.  Relationship and significance between anti-beta2-glycoprotein I antibodies and platelet activation state in patients with ulcerative colitis.

Authors:  Yan-Hang Gao; Pu-Jun Gao; Chun-Guang Wang; Xiao-Cong Wang; Yun-Feng Piao
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

5.  Coagulation parameters in inflammatory bowel disease.

Authors:  Can Dolapcioglu; Aliye Soylu; Tulin Kendir; Ali Tuzun Ince; Hatice Dolapcioglu; Sevim Purisa; Cengiz Bolukbas; Haci Mehmet Sokmen; Remzi Dalay; Oya Ovunc
Journal:  Int J Clin Exp Med       Date:  2014-05-15

6.  Clinical significance of serum procalcitonin in patients with ulcerative colitis.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Kazuki Takakura; Shunichi Odahara; Shintaro Tsukinaga; Toyokazu Yukawa; Jimi Mitobe; Mikio Kajihara; Kan Uchiyama; Hiroshi Arakawa; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

7.  Systemic and intestinal levels of factor XIII-A: the impact of inflammation on expression in macrophage subtypes.

Authors:  Christoffer Soendergaard; Peter Helding Kvist; Jakob Benedict Seidelin; Hermann Pelzer; Ole Haagen Nielsen
Journal:  J Gastroenterol       Date:  2015-12-11       Impact factor: 7.527

8.  Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis.

Authors:  Christina Andersson; Peter H Kvist; Kathryn McElhinney; Richard Baylis; Luise K Gram; Hermann Pelzer; Brian Lauritzen; Thomas L Holm; Simon Hogan; David Wu; Brian Turpin; Whitney Miller; Joseph S Palumbo
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

9.  Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study.

Authors:  Karsten Bernerth; Ingolf Schiefke; Karin Liebscher; Susanne Raczynski; Tanja Kottmann; Niels Teich
Journal:  BMC Res Notes       Date:  2018-12-04

10.  Thrombophilic Risk Factors in Patients With Inflammatory Bowel Disease.

Authors:  Ayten Yazici; Omer Senturk; Cem Aygun; Altay Celebi; Cigdem Caglayan; Sadettin Hulagu
Journal:  Gastroenterology Res       Date:  2010-05-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.